NEW YORK, Dec 4 (Reuters) - Nastech Pharmaceutical Co. (NSTK.O: Quote, Profile , Research) said on Monday that $15 million it expected to receive this year as part of a collaboration with Procter & Gamble(PG.N: Quote, Profile , Research) on an experimental osteoporosis drug would be deferred.